https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54994 Wed 27 Mar 2024 16:38:54 AEDT ]]> Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41947 Wed 22 Mar 2023 14:31:19 AEDT ]]> Quantifying the effect of location matching on accuracy of multiparametric magnetic resonance imaging prior to prostate biopsy—A multicentre study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37435 Mon 16 Nov 2020 17:39:51 AEDT ]]> Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45705 Fri 04 Nov 2022 08:48:56 AEDT ]]>